Company intelligence / Profile preview

RethinkFirst

New York, New York, United Statesrethinkfirst.com ↗

Ownership: Private
Employees: ~500
Development stage: Commercial

Overview

RethinkFirst’s cloud-based platform is commercially deployed worldwide to support evidence-based autism treatment and broader behavioral health management. The company reports positive outcomes such as reduced negative behavior incidents in schools and improved support for families of neurodiverse children. It claims the largest published ASD dataset and patent-pending solutions focused on data-driven care.

Therapeutic areas: PsychiatryNeurology
Modalities: Non-pharmacological therapy
Industry: Digital Health Medical Devices

Partnerships

Major clients include Fortune 500 companies (e.g., Volvo)US Department of Defensepublic school districts such as Houston ISDmanaged care organizations

Beyond the preview

Go deeper on RethinkFirst.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RethinkFirst.

Explore the full profile